Tower Research Capital (TRC)’s GLOBEIMMUNE INC COM STK (DE) GBIM Stock Holding History

Tower Research Capital (TRC)’s Portfolio GBIM Stock Details GBIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-230	Closed	–	–	5208
2016 Q2	$0	Sell	230 -180	-44%	-$319	﹤0.01%	5442
2016 Q1	$1K	Sell	410 -1,452	-78%	-$3.15K	﹤0.01%	3964
2015 Q4	$7K	Sell	1,862 -3,578	-66%	-$11.5K	﹤0.01%	2694
2015 Q3	$14K	Sell	5,440 -362	-6%	-$903	﹤0.01%	2073
2015 Q2	$15K	Buy	5,802 +4,501	+346%	+$28K	﹤0.01%	2383
2015 Q1	$10K	Sell	1,301 -2,268	-64%	-$16.4K	﹤0.01%	2831
2014 Q4	$27K	Sell	3,569 -189	-5%	-$1.32K	﹤0.01%	1406
2014 Q3	$26K	Buy	+3,758	New	+$38.4K	﹤0.01%	2101

Other funds holding GBIM

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Tower Research Capital (TRC)'s GBIM Position: Q3 2016 in Review

Tower Research Capital (TRC) sold out of GLOBEIMMUNE INC COM STK (DE) (GBIM) in Q3 2016, closing a stake of 230 shares.

Tower Research Capital (TRC) first reported a position in GBIM in Q3 2014 and held it in 8 quarters. The position peaked at $27K in Q4 2014. 1 fund tracked by Wall St. Rank holds GBIM as of Q3 2016.

Tower Research Capital (TRC) reported no remaining GLOBEIMMUNE INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Tower Research Capital (TRC) sold 230 GLOBEIMMUNE INC COM STK (DE) shares in Q3 2016.
Tower Research Capital (TRC) first reported a position in GLOBEIMMUNE INC COM STK (DE) in Q3 2014 and held it in 8 quarters.
Tower Research Capital (TRC)'s GLOBEIMMUNE INC COM STK (DE) position peaked at $27K in Q4 2014.
1 fund tracked by Wall St. Rank held GLOBEIMMUNE INC COM STK (DE) as of Q3 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.